VBLT logo

Vascular Biogenics (VBLT) Free Cash Flow

Annual FCF

-$32.41 M
-$5.96 M-22.52%

December 31, 2022

Summary

Performance

1-Year Change

-22.52%

3-Year Change

-146.21%

5-Year Change

-214.53%

15-Year Change

-214.53%

VBLT Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$10.30 M

3-Year Low

-$32.41 M
VBLT annual free cash flow is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
VBLT previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
VBLT next annual earnings announcement has not yet been scheduled

OtherVBLTcash flowmetrics:

Annual CFO

-$31.59 M
VBLT annual cash flow from operations is -$31.59 million

Annual CFF

$22.00 K
VBLT annual cash flow from financing activities is $22.00 thousand

Annual CFI

$27.30 M
VBLT annual cash flow from investing activities is $27.30 million

Annual CAPEX

$812.00 K
VBLT annual capital expenditures is $812.00 thousand

Quarterly FCF

-$2.36 M
-$674.00 K-39.93%

June 30, 2023

Summary

Performance

3-Month Change

-39.93%

1-Year Change

+76.75%

3-Year Change

+65.48%

5-Year Change

+50.61%

VBLT Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$7.93 M
VBLT quarterly free cash flow is currently -129.78% below its historical high of $7.93 million

3-Year Low

-$10.16 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
VBLT previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
VBLT next earnings announcement has not yet been scheduled

OtherVBLTcash flowmetrics:

Quarterly CFO

-$2.36 M
VBLT quarterly cash flow from operations is -$2.36 million

Quarterly CFF

$1000.00
VBLT quarterly cash flow from financing activities is $1000.00

Quarterly CFI

$186.00 K
VBLT quarterly cash flow from investing activities is $186.00 thousand

Quarterly CAPEX

-
VBLT quarterly capital expenditures value is unknown

TTM FCF

-$17.56 M
+$7.80 M+30.74%

June 30, 2023

Summary

Performance

3-Month Change

+30.74%

1-Year Change

+47.52%

3-Year Change

+14.95%

5-Year Change

-33.42%

VBLT TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$3.30 M

3-Year Low

-$33.47 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
VBLT previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
VBLT next earnings announcement has not yet been scheduled

OtherVBLTcash flowmetrics:

TTM CFO

-$17.59 M
VBLT TTM cash flow from operations is -$17.59 million

TTM CFF

$23.00 K
VBLT TTM cash flow from financing activities is $23.00 thousand

TTM CFI

$26.32 M
VBLT TTM cash flow from investing activities is $26.32 million

TTM CAPEX

-
VBLT TTM capital expenditures value is unknown

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

Annual FCF

-$32.41 M
VBLT annual free cash flow is -$32.41 million

Annual CFO

-$31.59 M
VBLT annual cash flow from operations is -$31.59 million

Annual CAPEX

$812.00 K
VBLT annual capital expenditures is $812.00 thousand

VBLT Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-22.5%+76.8%+47.5%
3 y3 years-146.2%+65.5%+14.9%
5 y5 years-214.5%+50.6%-33.4%

VBLT Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+22.5%at low+39.9%+330.1%at high+90.6%
5 y5-year+146.2%at low+39.9%+330.1%+33.4%+90.6%
alltimeall time+214.5%at low-129.8%+330.1%+431.7%+90.6%

Vascular Biogenics Free Cash Flow History

DateAnnualQuarterlyTTM
Jun 2023
-
-$2.36 M(+39.9%)
-$17.56 M(-30.7%)
Mar 2023
-
-$1.69 M(-74.9%)
-$25.36 M(-21.8%)
Dec 2022
-$32.41 M(+22.5%)
-$6.72 M(-1.0%)
-$32.41 M(-1.3%)
Sep 2022
-
-$6.79 M(-33.2%)
-$32.84 M(-1.9%)
Jun 2022
-
-$10.16 M(+16.3%)
-$33.47 M(+15.5%)
Mar 2022
-
-$8.74 M(+22.1%)
-$28.96 M(+9.5%)
Dec 2021
-$26.45 M(+12.9%)
-$7.16 M(-3.5%)
-$26.45 M(+1.1%)
Sep 2021
-
-$7.41 M(+31.0%)
-$26.16 M(+16.2%)
Jun 2021
-
-$5.66 M(-9.1%)
-$22.51 M(-5.0%)
Mar 2021
-
-$6.22 M(-9.4%)
-$23.70 M(+1.1%)
Dec 2020
-$23.43 M(+78.0%)
-$6.87 M(+82.5%)
-$23.43 M(+13.6%)
Sep 2020
-
-$3.76 M(-45.0%)
-$20.62 M(-0.1%)
Jun 2020
-
-$6.84 M(+14.9%)
-$20.65 M(+28.0%)
Mar 2020
-
-$5.96 M(+46.7%)
-$16.13 M(+22.5%)
Dec 2019
-$13.16 M(-26.5%)
-$4.06 M(+7.2%)
-$13.16 M(+8.3%)
Sep 2019
-
-$3.79 M(+62.9%)
-$12.15 M(-9.7%)
Jun 2019
-
-$2.33 M(-22.2%)
-$13.46 M(-15.4%)
Mar 2019
-
-$2.99 M(-2.1%)
-$15.92 M(-11.1%)
Dec 2018
-$17.91 M
-$3.05 M(-40.1%)
-$17.91 M(+158.7%)
Sep 2018
-
-$5.10 M(+6.6%)
-$6.92 M(-13.6%)
DateAnnualQuarterlyTTM
Jun 2018
-
-$4.78 M(-3.9%)
-$8.02 M(-16.0%)
Mar 2018
-
-$4.98 M(-162.8%)
-$9.54 M(-7.4%)
Dec 2017
-$10.30 M(-25.9%)
$7.93 M(-228.2%)
-$10.30 M(-52.6%)
Sep 2017
-
-$6.19 M(-1.9%)
-$21.74 M(+18.2%)
Jun 2017
-
-$6.31 M(+10.0%)
-$18.39 M(+17.9%)
Mar 2017
-
-$5.74 M(+63.5%)
-$15.60 M(+12.2%)
Dec 2016
-$13.90 M(+4.6%)
-$3.51 M(+23.6%)
-$13.90 M(-4.9%)
Sep 2016
-
-$2.84 M(-19.4%)
-$14.62 M(-6.5%)
Jun 2016
-
-$3.52 M(-12.8%)
-$15.64 M(+3.3%)
Mar 2016
-
-$4.04 M(-4.4%)
-$15.14 M(+13.9%)
Dec 2015
-$13.29 M(-3.4%)
-$4.22 M(+9.4%)
-$13.29 M(+14.9%)
Sep 2015
-
-$3.86 M(+27.6%)
-$11.56 M(-9.4%)
Jun 2015
-
-$3.02 M(+38.3%)
-$12.77 M(+1.0%)
Mar 2015
-
-$2.19 M(-12.3%)
-$12.64 M(-8.1%)
Dec 2014
-$13.76 M(+4.6%)
-$2.50 M(-50.7%)
-$13.76 M(+22.1%)
Sep 2014
-
-$5.06 M(+74.5%)
-$11.27 M(+81.6%)
Jun 2014
-
-$2.90 M(-12.2%)
-$6.20 M(+87.8%)
Mar 2014
-
-$3.30 M
-$3.30 M
Dec 2013
-$13.16 M(-0.0%)
-
-
Dec 2012
-$13.16 M
-
-

FAQ

  • What is Vascular Biogenics annual free cash flow?
  • What is the all time high annual FCF for Vascular Biogenics?
  • What is Vascular Biogenics annual FCF year-on-year change?
  • What is Vascular Biogenics quarterly free cash flow?
  • What is the all time high quarterly FCF for Vascular Biogenics?
  • What is Vascular Biogenics quarterly FCF year-on-year change?
  • What is Vascular Biogenics TTM free cash flow?
  • What is the all time high TTM FCF for Vascular Biogenics?
  • What is Vascular Biogenics TTM FCF year-on-year change?

What is Vascular Biogenics annual free cash flow?

The current annual FCF of VBLT is -$32.41 M

What is the all time high annual FCF for Vascular Biogenics?

Vascular Biogenics all-time high annual free cash flow is -$10.30 M

What is Vascular Biogenics annual FCF year-on-year change?

Over the past year, VBLT annual free cash flow has changed by -$5.96 M (-22.52%)

What is Vascular Biogenics quarterly free cash flow?

The current quarterly FCF of VBLT is -$2.36 M

What is the all time high quarterly FCF for Vascular Biogenics?

Vascular Biogenics all-time high quarterly free cash flow is $7.93 M

What is Vascular Biogenics quarterly FCF year-on-year change?

Over the past year, VBLT quarterly free cash flow has changed by +$7.80 M (+76.75%)

What is Vascular Biogenics TTM free cash flow?

The current TTM FCF of VBLT is -$17.56 M

What is the all time high TTM FCF for Vascular Biogenics?

Vascular Biogenics all-time high TTM free cash flow is -$3.30 M

What is Vascular Biogenics TTM FCF year-on-year change?

Over the past year, VBLT TTM free cash flow has changed by +$15.90 M (+47.52%)